Trials / Completed
CompletedNCT00035516
A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- R-Pharm · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical research study is to learn if BMS-247550 can shrink or slow the growth of the cancer in patients with non-small cell lung cancer who have failed first-line platinum based chemotherapy. The safety of this treatment will also be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epothilone |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2004-04-01
- Completion
- 2004-04-01
- First posted
- 2002-05-06
- Last updated
- 2016-02-10
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035516. Inclusion in this directory is not an endorsement.